Drug Type Small molecule drug |
Synonyms Antioxidant (Garvan Institute of Medical Research) |
Mechanism Uncoupling protein stimulators, Mitochondrial oxidative phosphorylation uncouplers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 04 Apr 2023 | |
Acute kidney injury due to sepsis | Preclinical | US | 05 Nov 2019 | |
Reperfusion Injury | Preclinical | US | 01 Apr 2014 | |
Reperfusion Injury | Preclinical | US | 01 Apr 2014 | |
Insulin Resistance | Preclinical | AU | - | |
Obesity | Preclinical | AU | - | |
Sarcopenia | Discovery | AU | - |